VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

Texas MPN Workshop 2022 | Targeting the BCLxL pathway in MPNs

Naveen Pemmaraju, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, briefly explains the importance of targeting novel pathways in myeloproliferative neoplasms (MPNs), drawing focus on targeting the BCLxL pathway with navitoclax. This interview took place at the third annual Texas MPN Workshop (TMW) 2022, held in San Antonio, TX.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter